C. Borgoño and E. Diamandis, The emerging roles of human tissue kallikreins in cancer, Nature Reviews Cancer, vol.169, issue.11, pp.876-90, 2004.
DOI : 10.1038/nrc1474

S. Hutchinson, L. Luo, G. Yousef, A. Soosaipillai, and E. Diamandis, Purification of Human Kallikrein 6 from Biological Fluids and Identification of its Complex with ??1-Antichymotrypsin, Clinical Chemistry, vol.49, issue.5, pp.746-51, 2003.
DOI : 10.1373/49.5.746

C. Petraki, V. Karavana, P. Skoufogiannis, S. Little, D. Howarth et al., The Spectrum of Human Kallikrein 6 (Zyme/Protease M/Neurosin) Expression in Human Tissues as Assessed by Immunohistochemistry, Journal of Histochemistry & Cytochemistry, vol.49, issue.11, pp.1431-1472, 2001.
DOI : 10.1177/002215540104901111

C. Petraki, P. Papanastasiou, V. Karavana, and E. Diamandis, Cellular distribution of human tissue kallikreins: immunohistochemical localization, Biological Chemistry, vol.387, issue.6, pp.653-63, 2006.
DOI : 10.1515/BC.2006.084

J. Shaw and E. Diamandis, Distribution of 15 Human Kallikreins in Tissues and Biological Fluids, Clinical Chemistry, vol.53, issue.8, pp.1423-1455, 2007.
DOI : 10.1373/clinchem.2007.088104

J. Singh, A. Naran, N. Misso, P. Rigby, P. Thompson et al., Expression of kallikrein-related peptidases (KRP/hK5, 7, 6, 8) in subtypes of human lung carcinoma, International Immunopharmacology, vol.8, issue.2, pp.300-306, 2008.
DOI : 10.1016/j.intimp.2007.08.015

M. Paliouras and E. Diamandis, The kallikrein world: an update on the human tissue kallikreins, Biological Chemistry, vol.387, issue.6, pp.643-52, 2006.
DOI : 10.1515/BC.2006.083

A. Santin, E. Diamandis, S. Bellone, A. Soosaipillai, S. Cane et al., Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer, Clinical Cancer Research, vol.11, issue.9, pp.3320-3325, 2005.
DOI : 10.1158/1078-0432.CCR-04-2528

M. Zarghooni, A. Soosaipillai, L. Grass, A. Scorilas, N. Mirazimi et al., Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer???s disease patients, Clinical Biochemistry, vol.35, issue.3, pp.225-256, 2002.
DOI : 10.1016/S0009-9120(02)00292-8

B. Klucky, R. Mueller, I. Vogt, S. Teurich, B. Hartenstein et al., Kallikrein 6 Induces E-Cadherin Shedding and Promotes Cell Proliferation, Migration, and Invasion, Cancer Research, vol.67, issue.17, pp.8198-206, 2007.
DOI : 10.1158/0008-5472.CAN-07-0607

H. Nagahara, K. Mimori, T. Utsunomiya, G. Barnard, M. Ohira et al., Clinicopathologic and Biological Significance of Kallikrein 6 Overexpression in Human Gastric Cancer, Clinical Cancer Research, vol.11, issue.19, pp.6800-6806, 2005.
DOI : 10.1158/1078-0432.CCR-05-0943

M. Ghosh, L. Grass, A. Soosaipillai, G. Sotiropoulou, and E. Diamandis, Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells, Tumor Biology, vol.79, issue.4, pp.193-202, 2004.
DOI : 10.1016/0022-2836(83)90077-3

C. Planque, M. De-monte, S. Guyetant, J. Rollin, C. Desmazes et al., KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer, Biochemical and Biophysical Research Communications, vol.329, issue.4, pp.1260-1266, 2005.
DOI : 10.1016/j.bbrc.2005.02.100

C. Planque, M. Aïnciburu, N. Heuzé-vourc-'h, S. Régina, M. De-monte et al., Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and noncancerous lung tissues, Biol Chem, vol.387, pp.783-791, 2006.

A. Barascu, P. Besson, L. Floch, O. Bougnoux, P. Jourdan et al., CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells, The International Journal of Biochemistry & Cell Biology, vol.38, issue.2, pp.196-208, 2006.
DOI : 10.1016/j.biocel.2005.08.015
URL : https://hal.archives-ouvertes.fr/inserm-00068760

N. Heuzé-vourc-'h, M. Liu, H. Dalwadi, F. Baratelli, L. Zhu et al., IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression, Biochemical and Biophysical Research Communications, vol.333, issue.2, pp.470-475, 2005.
DOI : 10.1016/j.bbrc.2005.05.122

D. Cox, Regression Models and Life-Tables, J of the Royal Statistical Society, vol.34, pp.187-220, 1972.
DOI : 10.1007/978-1-4612-4380-9_37

C. Reynaud and Y. Courty, Recombinant kallikrein expression: site-specific integration for hK6 production in human cells, Biol Chem, vol.387, pp.687-95, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00141276

M. Zajac-kaye, Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer, Lung Cancer, vol.34, pp.43-49, 2001.
DOI : 10.1016/S0169-5002(01)00343-9

S. Pelengaris, M. Khan, and G. Evan, c-MYC: more than just a matter of life and death, Nature Reviews Cancer, vol.15, issue.10, pp.764-76, 2002.
DOI : 10.1038/nrc904

A. Gartel and K. Shchors, Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes, Experimental Cell Research, vol.283, issue.1, pp.17-21, 2003.
DOI : 10.1016/S0014-4827(02)00020-4

C. Planque, C. Bléchet, A. Ayadi-kaddour, N. Heuzé-vourc-'h, P. Dumont et al., Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung, Biological Chemistry, vol.389, issue.6, pp.781-787, 2008.
DOI : 10.1515/BC.2008.089

Y. Sher, C. Chou, R. Chou, H. Wu, W. Chang et al., Human Kallikrein 8 Protease Confers a Favorable Clinical Outcome in Non-Small Cell Lung Cancer by Suppressing Tumor Cell Invasiveness, Cancer Research, vol.66, issue.24, pp.11763-70, 2006.
DOI : 10.1158/0008-5472.CAN-06-3165

B. Li, J. Goyal, S. Dhar, G. Dimri, E. Evron et al., CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression, Cancer Res, vol.61, pp.8014-8035, 2001.

D. Smiraglia, L. Rush, M. Frühwald, Z. Dai, W. Held et al., Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies, Human Molecular Genetics, vol.10, issue.13, pp.1413-1422, 2001.
DOI : 10.1093/hmg/10.13.1413

G. Pampalakis and G. Sotiropoulou, Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer, Biological Chemistry, vol.387, issue.6, pp.773-82, 2006.
DOI : 10.1515/BC.2006.097

T. Tlsty and L. Coussens, TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENT, Annual Review of Pathology: Mechanisms of Disease, vol.1, issue.1, pp.119-50, 2006.
DOI : 10.1146/annurev.pathol.1.110304.100224

G. Pampalakis and G. Sotiropoulou, Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1776, issue.1, pp.22-31, 2007.
DOI : 10.1016/j.bbcan.2007.06.001

M. Blagosklonny and A. Pardee, The Restriction Point of the Cell Cycle, Cell Cycle, vol.1, issue.2, pp.103-113, 2002.
DOI : 10.4161/cc.1.2.108

D. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global Cancer Statistics, 2002, CA: A Cancer Journal for Clinicians, vol.55, issue.2, pp.74-108, 2002.
DOI : 10.3322/canjclin.55.2.74

C. Planque, L. Li, Y. Zheng, A. Soosaipillai, K. Reckamp et al., A Multiparametric Serum Kallikrein Panel for Diagnosis of Non-Small Cell Lung Carcinoma, Clinical Cancer Research, vol.14, issue.5, pp.1355-62, 2008.
DOI : 10.1158/1078-0432.CCR-07-4117